Poolbeg Financial Statements From 2010 to 2025
| POLBF Stock | USD 0.04 0.00 0.00% |
Check Poolbeg Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Poolbeg Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Poolbeg financial statements analysis is a perfect complement when working with Poolbeg Pharma Valuation or Volatility modules.
Poolbeg |
Poolbeg Pharma PLC Company Shares Outstanding Analysis
Poolbeg Pharma's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Poolbeg Pharma Shares Outstanding | 500 M |
Most of Poolbeg Pharma's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Poolbeg Pharma PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Poolbeg Pharma PLC has 500 M of shares currently outstending. This is 176.96% higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The shares outstanding for all United States stocks is 12.56% higher than that of the company.
Poolbeg Pharma PLC Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Poolbeg Pharma's current stock value. Our valuation model uses many indicators to compare Poolbeg Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Poolbeg Pharma competition to find correlations between indicators driving Poolbeg Pharma's intrinsic value. More Info.Poolbeg Pharma PLC is considered to be number one stock in shares outstanding category among its peers. It is rated below average in shares owned by insiders category among its peers . The ratio of Shares Outstanding to Shares Owned By Insiders for Poolbeg Pharma PLC is about 25,548,005 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Poolbeg Pharma's earnings, one of the primary drivers of an investment's value.About Poolbeg Pharma Financial Statements
Poolbeg Pharma stakeholders use historical fundamental indicators, such as Poolbeg Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Although Poolbeg Pharma investors may analyze each financial statement separately, they are all interrelated. For example, changes in Poolbeg Pharma's assets and liabilities are reflected in the revenues and expenses on Poolbeg Pharma's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Poolbeg Pharma PLC. Please read more on our technical analysis and fundamental analysis pages.
Poolbeg Pharma plc operates as a clinical stage infectious disease pharmaceutical company in the United Kingdom. Poolbeg Pharma plc was incorporated in 2021 and is headquartered in London, the United Kingdom. Poolbeg Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 7 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Poolbeg Pink Sheet
Poolbeg Pharma financial ratios help investors to determine whether Poolbeg Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Poolbeg with respect to the benefits of owning Poolbeg Pharma security.